Embecta (EMBC) Cash from Investing Activities (2020 - 2026)
Embecta (EMBC) posted Cash from Investing Activities of -$500000.0 for Q1 2026, down 105.26% sequentially from $9.5 million in Q4 2025, and down 400.0% YoY from $166666.7 in Q1 2025.
Embecta (EMBC) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Embecta has reported Cash from Investing Activities for 7 years, with the latest figure at -$500000.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 400.0% year-over-year to -$500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 111.5% YoY) and the FY2025 annual result came in at -$9.3 million, up 41.14% from the prior year.
- Cash from Investing Activities retreated to -$500000.0 in Q1 2026 per EMBC's latest filing, from $9.5 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $9.5 million in Q4 2025 and troughed at -$9.7 million in Q2 2024.
- A 5-year average of -$3.9 million and a median of -$5.0 million in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities soared 733.33% in 2025, then slumped 400.0% in 2026.
- Over 5 years, Cash from Investing Activities stood at -$4.7 million in 2022, then jumped by 42.55% to -$2.7 million in 2023, then surged by 44.44% to -$1.5 million in 2024, then jumped by 733.33% to $9.5 million in 2025, then plunged by 105.26% to -$500000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$500000.0, $9.5 million, and -$7.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | -129.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -129.50 Mn |
| Jun 30, 2026 | -129.50 Mn |
| Mar 31, 2026 | -500,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Dec 31, 2025 | 9.50 Mn |
| Dec 31, 2025 | 9.50 Mn |
| Sep 30, 2025 | -7.30 Mn |
| Sep 30, 2025 | -7.30 Mn |
| Jun 30, 2025 | -400,000.00 |
| Jun 30, 2025 | -400,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Jun 30, 2024 | -9.70 Mn |
| Jun 30, 2024 | -9.70 Mn |
| Mar 31, 2024 | -3.40 Mn |
| Mar 31, 2024 | -3.40 Mn |
| Dec 31, 2023 | -2.70 Mn |
| Dec 31, 2023 | -2.70 Mn |